(3,4-DiMethoxyphenyl)acetyl chloride CAS: 10313-60-7

Product Parameters
Catalog No. BK5EL6
CAS.RN 10313-60-7
Molecular Formula C10H11ClO3
Molecular Weight 214.65 g/mol
Purity NLT 98%
Product Overview

(3,4-Dimethoxyphenyl)acetyl chloride is an important pharmaceutical intermediate widely used in organic synthesis and drug molecule construction, playing a crucial role, especially in the synthesis of antitumor and anti-inflammatory drugs. This product is suitable for small-scale preparation, pilot-scale amplification, and commercial production stages in early drug development. It can serve as a key starting material or structural modification unit, meeting the needs of process development at different scales, and is one of the indispensable core compounds in the field of pharmaceutical chemistry.

Applications
  • Drug molecule structure modification and synthesis
  • Development of antitumor drug intermediates
  • Synthesis of anti-inflammatory compounds
  • Preparation of pharmaceutical active ingredient precursors
  • Customized drug intermediate synthesis
Quality & Supply Capability

English Name: (3,4-DiMethoxyphenyl)acetyl chloride Properties: This product is a white to off-white crystalline powder with a stable aromatic ring structure and active acyl chloride functional groups. It readily reacts with nucleophiles such as amines and alcohols, making it suitable for various organic synthesis pathways. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific details. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process supply service from laboratory samples to industrial-scale production. We can provide small-scale preparation, pilot-scale amplification, and customized batch production solutions according to customer needs. We also support flexible configuration based on customer requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. We have a professional technical team that can provide customers with comprehensive technical support from laboratory R&D to scale-up production, helping customers efficiently advance process development, route optimization, and project transformation.

Why Choose Bioncan

Focused on pharmaceutical intermediates, possessing extensive synthesis experience and technological expertise. Full-scale supply capability, covering all stages from laboratory to commercial production. Provides complete quality control documentation, including COA, MSDS, HPLC, NMR, etc. Supports customized needs, adjusting product specifications and packaging according to specific customer requirements. Comprehensive process optimization and scale-up technical support to help customers achieve efficient commercialization.

Intermediates of Ivabradine hydrochloride
Catalog No. Product Name CAS
BA05GW Ivabradine hydrochloride API 148849-67-6
BK82Q4 4,5-Dimethoxy-1-cyanobenzocyclobutane 35202-54-1
BK598V (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride 866783-13-3
BK33FJ 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one 73942-87-7
BK56VJ (S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methylmethanamine 866783-12-2
BK206L Dehydro ivabradine 1086026-31-4
BK4YJ2 N-(3-Bromopropyl)-Phthalimide 5460-29-7
BK3E8G 2,2-Dimethoxy acetaldehyde 51673-84-8
BK40K6 1,1-Diethoxyethene 2678-54-8
BK9D07 The metabolite of ivabradine 215935-23-2
BK752T 3,4-DimethoxyPhenylethylamine 120-20-7
BK364P C-(3,4-DIMETHOXY-BICYCLO[4.2.0]OCTA-1(6),2,4-TRIEN-7-YL)-METHYLAMINE 73344-75-9
BK96F9 (3,4-DiMethyoxy-bicyclo(4,2,0)octa-1(6),2,4-trien-7-ylMethyl)-carbaMic acid ethyl ester 148870-55-7
BK8YQ4 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one 148870-57-9
BK7CK9 Propanedioic acid, 2-​(2-​bromo-​4,​5-​dimethoxyphenyl)​-​, 1,​3-​dimethyl ester 1069115-30-5
BK1AT9 Bicyclo[4.2.0]​octa-​1,​3,​5-​triene-​7,​7-​dicarboxylic acid, 3,​4-​dimethoxy-​, 7,​7-​dimethyl ester 1069115-32-7
BK9Z16 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one hydrochloride 163629-94-5
BK813C 4,5-diMethoxy-N-Methyl-1,2-dihydrocyclobutabenzene-1-carboxaMide 1206230-27-4
BK2BU0 3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 148870-58-0
BK2PD7 3-(3-(((S)-4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one hydrochloride 1393427-01-4
BK5KH5 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-02-5
BK45M1 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(2,2-dimethoxyethyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-03-6
BK5EL6 (3,4-DiMethoxyphenyl)acetyl chloride 10313-60-7
BK8E10 7,8-Dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)acetyl)(methyl)amino)propyl)-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-04-7
BK2YU2 4,5-DIBROMOVERATROLE 37895-73-1
BK67FH (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1-oxide 1132079-01-6
BK2Z7N (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2-oxo-2,3-dihydro-1H-benzo[d]azepin-1-ium chloride 1246638-10-7
BK0F52 Bicyclo[4.2.0]​octa-​1,​3,​5-​triene-​7-​carboximidamide, 3,​4-​dimethoxy-​N-​methyl-​N-​[3-​(1,​2,​4,​5-​tetrahydro-​7,​8-​dimethoxy-​2-​oxo-​3H-​3-​benzazepin-​3-​yl)​propyl]​- 1246672-58-1
BK8Q64 7,8-Dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-2,3-dihydro-1H-benzo[d]azepin-2-one 98062-25-0
BK85JV 3-chloro-N-{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}-N-methyl-1-propanamine 1031767-71-1
BK5F84 (S)-N-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)-N-methyl-3-(7,8-dimethoxy-2-oxo-2,3-dihydro-1H-benzo[d]azepin-3-yl)propan-1-aminium chloride 1325209-22-0
BK515P (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one sulfate 1325209-23-1
BK5J56 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one mesylate 1325209-25-3
BK32MX (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one hydrobromide 1325209-24-2
BK1E79 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one phosphate 1325209-26-4
BK36R2 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one acetate 1325209-27-5
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 10313-60-7, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.